恩瑞格多少钱一盒？

It is an oral active chelating agent with high selectivity for iron (Fe3+). It is a ligand with three protrusions and binds iron with high affinity in a ratio of 2:1. Enriga is a drug approved to reduce iron burden and was developed by the Swiss pharmaceutical company Novartis. India's Cipla's Enriga is a generic drug, so how much does a box of India's Cipla's Enriga cost?

Enrig has been included in medical insurance, but reimbursement rates vary from place to place, and long-term use is still relatively expensive. Enrig India’s Cipla Desirox 500mg*30 tablets are priced at about $240. Patients in need can purchase the drug abroad or obtain the drug through domestic professional overseas medical service organizations (such as Medical Companion Travel), and have it shipped directly to their homes, ensuring authenticity.

India's Cipla is the second largest pharmaceutical company in India, with strong financial and scientific research capabilities. Especially its cheap anti-AIDS and anti-cancer drugs are very popular among patients in developing countries. A generic drug is a copy of a brand-name drug that is identical in dosage, safety, potency (regardless of how it is taken), quality, effects, and indications. Enreg is one of these generic drugs.

Enrig dispersible tablets are mainly suitable for patients with iron accumulation due to long-term blood transfusion (such as thalassemia or other rare anemias). It is suitable for children over two years old and adults. Enriga should not be used with other iron chelation treatments as the safety of such combined use has not been established.

Enrego was the first oral iron chelator approved by the FDA for routine use in 2005 and is currently available in more than 80 countries. The oral suspension and dispersible tablets marketed in the United States are approved for the treatment of chronic iron overload due to transfusion in adult and pediatric patients 2 years and older and for the treatment of chronic iron overload in patients 10 years and older with non-transfusion-dependent thalassemia (NTDT) syndrome.